ResearcherChiba UniversityActive in the last 2 years

Akinori Abe

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0009-0002-9137-8553; OpenAlex author ID A5124115549. Sources: OpenAlex.

Their work

Papers: 2
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 7

Papers, trials and grants by year

2026: 2 papers

Papers 2

A Real-world Study on the Prognosis of Patients with Pancreatic Cancer: A Prospective Stationary Survey from 2007-2020. Co-author DOI 10.2169/internalmedicine.6719-25 ↗
Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectable Pancreatic Cancer: A Single-Center Re… Co-author DOI 10.3390/cancers18020194 ↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Jun Kato · 2 shared papers, 2026 · strength 0.46
- Paper A Real-world Study on the Prognosis of Patients with Pancreatic Cancer: A Prospective Stationary Survey from 2007-2020. DOI 10.2169/internalmedicine.6719-25 ↗
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194 ↗
Hiroshi Ohyama · 2 shared papers, 2026 · strength 0.46
- Paper A Real-world Study on the Prognosis of Patients with Pancreatic Cancer: A Prospective Stationary Survey from 2007-2020. DOI 10.2169/internalmedicine.6719-25 ↗
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194 ↗
Masao Omata · 1 shared paper, 2026 · strength 0.23
- Paper A Real-world Study on the Prognosis of Patients with Pancreatic Cancer: A Prospective Stationary Survey from 2007-2020. DOI 10.2169/internalmedicine.6719-25 ↗
Motoyasu Kan · 1 shared paper, 2026 · strength 0.23
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194 ↗
Shigetsugu Takano · 1 shared paper, 2026 · strength 0.23
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194 ↗
Kazuki Watabe · 1 shared paper, 2026 · strength 0.23
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194 ↗
Masayuki Ohtsuka · 1 shared paper, 2026 · strength 0.23
- Paper Prognostic Impact of Unplanned Hospitalization During First-Line Gemcitabine Plus Nab-Paclitaxel Therapy for Unresectab… DOI 10.3390/cancers18020194 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.